Avg closing price
Price range

7 Cathie Wood Beam Therapeutics Trades

Cathie Wood's position in Beam Therapeutics is currently worth $421 Million. That's 3.08% of their equity portfolio (11th largest holding). The investor owns 12.60% of the outstanding Beam Therapeutics stock. The investor's estimated purchase price is $710 Million, resulting in a loss of 41%.

Avg closing price
Price range
Increased shares by 7.2% (+591 Thousand shares) Q2 2022
Avg closing price $39.75
Price range $29.86 - $62.36
Increased shares by 2.7% (+217 Thousand shares) Q1 2022
Avg closing price $65.59
Price range $53.73 - $82.16
Increased shares by 16.7% (+1.14 Million shares) Q4 2021
Avg closing price $85.62
Price range $68.02 - $99.06
Increased shares by 5.9% (+380 Thousand shares) Q3 2021
Avg closing price $100.46
Price range $84.37 - $133.60
Increased shares by 35.2% (+1.68 Million shares) Q2 2021
Avg closing price $79.68
Price range $64.12 - $128.71
Increased shares by 322.3% (+3.65 Million shares) Q1 2021
Avg closing price $95.13
Price range $71.28 - $120.75
New holding (+1.13 Million shares) Q4 2020
Avg closing price $49.18
Price range $22.24 - $95.63

News about Beam Therapeutics Inc and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!